Lantern Pharma YTD Return
The LTRN YTD return is -5.28% with dividends reinvested through 07/17/2026. Investors often use YTD return to compare year-to-date performance across securities because current calendar year return information is important for tax planning.
This page shows LTRN YTD return, annualized return, start and end dates, and the growth of a hypothetical $10,000 investment with dividends reinvested.
| LTRN YTD Return Table | ||||||||||||||||||||||||||||||
LTRN YTD return is presented with the assumption of reinvestments of any dividends on ex-date. |
| YTD Return Benchmarks |
|
Use our YTD Return Calculator to
compare LTRN YTD return versus benchmarks: YTD Return for S&P YTD Return for Dow YTD Return for Nasdaq 100 YTD Return for Russell 2000 YTD Return for Gold YTD Return for 10 Year Treasury |
| LTRN Share Performance |
| LTRN YTD Return Chart | |||
Also see: LTRN Average Annual Return | |||
| About Lantern Pharma Inc |
| Lantern Pharma Inc. is an artificial intelligence (AI) company. Co. is developing targeted and transformative cancer therapies using its proprietary RADR AI and machine learning (ML) platform with multiple clinical-stage drug programs. Its proprietary AI and machine learning (ML) platform, RADR, leverages over 60 billion oncology-focused data points and a library of over 200 advanced ML algorithms to help solve problems in oncology drug development. It is engaged in the development of its pipeline of therapies that span multiple cancer indications, including both solid tumors and blood cancers and an antibody drug conjugate (ADC) program. The LTRN YTD return is shown above.
The YTD Return on the LTRN YTD return page and across the coverage universe of our site, is a measure of the total return for a given investment year-to-date for the current calendar year (up to the end of prior trading session). Arguably, choosing the current calendar year for a measurement period is on the one hand completely arbitrary, but on the other hand a year-to-date look can be extremely useful in the context of our country's tax system which taxes gains and income on a calendar year basis. Thus, researching Year-To-Date Returns is good practice for investors — whether LTRN YTD return or other benchmarks/peers — and when doing so it is also important to factor in dividends, because a financial instrument's YTD return is more than just the change in price if that instrument pays a dividend or coupon. Our website aims to empower investors by performing the LTRN YTD return calculation (with any dividends reinvested as applicable), and to provide a coverage universe of many stocks and ETFs to be able to compare YTD returns. |
| LTRN Current Stock Quote |
Quotes delayed 20 minutes  Free LTRN Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| Video: Don't Forget Dividends in YTD Return! | |
|
| YTD Return Peers |
| Lantern Pharma (LTRN) is categorized under the Healthcare sector; to help you further research YTD return performance across stocks, below are some other companies in the same sector:
LUCD YTD Return LUMO YTD Return LUNG YTD Return LVGO YTD Return LXEO YTD Return LXRX YTD Return LYEL YTD Return LYRA YTD Return MACK YTD Return MASI YTD Return More Healthcare companies » |
Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.
You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.
Video: Don't Forget Dividends in YTD Return!